Your Daily Dose of Financial News

Robins Kaplan LLP
Contact

Robins Kaplan LLP

The Supreme Court, still plugging along with just 8 Justices, heard arguments yesterday on its first insider-trading case in two decades – NYTimes and WSJ and Law360

Theranos is “retreating” from its blood tests, cutting its workforce by 40 percent, and shuttering facilities—all signs that Elizabeth Holmes’ company may be shifting to developing products to sell to outside labs rather than pursuing its own blood testing ambitions – WSJ and Bloomberg

Paul Singer’s Elliott Management hedge fund has set its activist sights on South Korea’s Samsung conglomerate—a “chaebol” run by the powerful Lee family dynasty – NYTimes and WSJ

NYSE regulators have opened a probe into the Monday decisions of an IMC market maker (charged with helping stocks trade in an orderly fashion, especially during special events) based on the wild ride of Versum Materials shares that day – WSJ

The IMF didn’t name names in its official report on financial stability risks worldwide, but its officials had no problem putting Deutsche Bank on blast in the news conference held to discuss the study’s findings – NYTimes

A photographic display from the Times on the almost incomprehensible scale of the US’s industrialized food system – NYTimes

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Robins Kaplan LLP | Attorney Advertising

Written by:

Robins Kaplan LLP
Contact
more
less

Robins Kaplan LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide